Everything You Need to Know About Fall and Winter Vaccinations – Q&A with Seattle Children’s Pediatric Infectious Disease Research Group

As summer starts to cool down, parents are all too familiar with the return of back to school prep and fun fall activities. While families are busy checking off school supply lists and spending more time indoors through the chillier months, it might be easy to overlook the preventive care to help keep children safe […]

Read More →

The Next Generation of Researchers: SCRI Summer Scholars Program Provides Path to Science Careers

This story is part two of an On the Pulse series. Read part one here.  Seattle Children’s Research Institute (SCRI) is one of the nation’s leading pediatric research facilities, with talented investigators who have made stunning breakthroughs in their ongoing efforts to help every child live a full, healthy life. Working to inspire and develop […]

Read More →

Spotlight on Invent@SC’s Future Biotech Leaders: Meet Seattle Children’s Dr. Edward Song

Founded in 2022, the Invent at Seattle Children’s Postdoctoral Scholars Program is a first-in-the nation postdoctoral training program that aspires to develop novel therapeutics at Seattle Children’s. The program is an investment in training talented early career scientists historically underrepresented in biotech in the development of therapeutics for childhood diseases. It seeks to improve the […]

Read More →

Top 5 Things to Know about Malaria, According to a Seattle Children’s Infectious Disease Researcher

Eight cases of locally acquired malaria have been confirmed in Florida and Texas this summer, marking the first time in 20 years locally transmitted cases have been seen, and decades since malaria was officially eradicated in the United States. Although about 2,000 Americans are diagnosed with malaria each year, those cases are linked with travel […]

Read More →

Seattle Children’s Cancer Leaders Recognized for Continued Efforts to Develop and Discover Better Treatments and Cures

In Seattle Children’s Cancer and Blood Disorders Center (CBDC), patients are treated for some of the most complex and rare conditions seen in children, teens and young adults. Close ties and dual roles between the CBDC care team and Seattle Children’s researchers extends a unique, team approach to treating pediatric patients in their fight against […]

Read More →

Research Highlights: Equity Initiatives Improve Infection Rates; Cell and Gene Therapy Progress; Malaria Study

As one of the nation’s top four pediatric research centers, Seattle Children’s Research Institute remains dedicated to providing hope, care and cures to help every child live the healthiest and most fulfilling life possible. On the Pulse takes a look at some of the highlights from across the research institute over the past month.  

Read More →

Seattle Children’s Lead DIPG Researcher Attends Brain Cancers Forum at The White House

The White House recently convened patients, caregivers, oncologists, researchers and administration officials for the Cancer Moonshot Brain Cancers Forum as the administration moves to advance progress for patients with glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG). Among the attendees invited was Dr. Nicholas Vitanza, an attending physician in Seattle Children’s Cancer and Blood Disorders […]

Read More →

Seattle Children’s Trial Medication Stops Emree’s Seizures

It’s been 12 years, but Brandy Epling still chokes up at the traumatic memory of her firstborn’s birth. It was a difficult pregnancy, with preterm labor forcing a 33-day stay at a southwest Washington hospital for the mom-to-be, followed by months of bedrest. Ultrasounds revealed the baby’s brain was a bit bigger on the left […]

Read More →

Seattle Children’s Launches Pioneering Immunotherapy Clinical Trial Targeting Four Antigens at the Same Time to Combat Pediatric Brain and Spinal Cord Tumors

Seattle Children’s Therapeutics has launched BrainChild-04, a first-in-human phase 1 clinical trial that will be our first chimeric antigen receptor (CAR) T-cell clinical trial that targets four antigens at the same time, by delivering CAR T cells directly to the brain. The trial is for children, teens, and young adults with diffuse intrinsic pontine glioma […]

Read More →